Explorative visual analytics on interval-based genomic data and their metadata

BMC Bioinformatics

Table 1 Datasets of human A549 immortalized cell line used for GeMSE demonstration

#	Treatment	Dose	Duration	Antibody target	Replicates
1	Dexamethasone	500 pM	1 h	NR3C1	∙∙
2	Dexamethasone	5 nM	1 h	NR3C1	∙∙
3	Dexamethasone	50 nM	1 h	NR3C1	∙∙
4	Dexamethasone	100 nM	30 m	JUNB	∙∙
5	Dexamethasone	100 nM	0 h	JUNB	∙∙
6	Dexamethasone	100 nM	1 h	JUNB	∙∙
7	Dexamethasone	100 nM	2 h	JUNB	∙∙
8	Dexamethasone	100 nM	3 h	JUNB	∙∙∙
9	Dexamethasone	100 nM	4 h	JUNB	∙∙∙
10	Dexamethasone	100 nM	5 h	JUNB	∙∙∙
11	Dexamethasone	100 nM	7 h	JUNB	∙∙∙
12	Dexamethasone	100 nM	8 h	JUNB	∙∙∙
13	Dexamethasone	100 nM	10 h	JUNB	∙∙
14	Dexamethasone	100 nM	1 h	FOXA1	∙∙
15	Dexamethasone	100 nM	1 h	POLR2A	∙∙
16	Dexamethasone	100 nM	1 h	USF1	∙∙
17	Ethanol	0.02 %	1 h	ATF3	∙∙∙
18	Ethanol	0.02 %	1 h	BCL3	∙∙
19	Ethanol	0.02 %	1 h	CTCF	∙∙
20	Ethanol	0.02 %	1 h	EP300	∙∙
21	Ethanol	0.02 %	1 h	GABPA	∙∙
22	Ethanol	0.02 %	1 h	JUND	∙∙
23	Ethanol	0.02 %	1 h	POLR2A	∙∙
24	Ethanol	0.02 %	1 h	REST	∙∙
25	Ethanol	0.02 %	1 h	SIN3A	∙∙
26	Ethanol	0.02 %	1 h	SIX5	∙∙
27	Ethanol	0.02 %	1 h	TAF1	∙∙
28	Ethanol	0.02 %	1 h	TCF12	∙∙
29	Ethanol	0.02 %	1 h	USF1	∙∙
30	None	None	None	CTCF	∙∙
31	None	None	None	PBX3	∙∙
32	None	None	None	RAD21	∙∙
33	None	None	None	TEAD4	∙∙

ISSN: 1471-2105